BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

359 related articles for article (PubMed ID: 15944105)

  • 1. Use of complementary and alternative medicine among cancer patients in Israel.
    Pud D; Kaner E; Morag A; Ben-Ami S; Yaffe A
    Eur J Oncol Nurs; 2005 Jun; 9(2):124-30. PubMed ID: 15944105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complementary and alternative medicine use in lung cancer patients in eight European countries.
    Molassiotis A; Panteli V; Patiraki E; Ozden G; Platin N; Madsen E; Browall M; Fernandez-Ortega P; Pud D; Margulies A
    Complement Ther Clin Pract; 2006 Feb; 12(1):34-9. PubMed ID: 16401528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complementary and alternative medicine use in colorectal cancer patients in seven European countries.
    Molassiotis A; Fernandez-Ortega P; Pud D; Ozden G; Platin N; Hummerston S; Scott JA; Panteli V; Gudmundsdottir G; Selvekerova S; Patiraki E; Kearney N
    Complement Ther Med; 2005 Dec; 13(4):251-7. PubMed ID: 16338195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complementary and alternative medicine use in patients with haematological malignancies in Europe.
    Molassiotis A; Margulies A; Fernandez-Ortega P; Pud D; Panteli V; Bruyns I; Scott JA; Gudmundsdottir G; Browall M; Madsen E; Ozden G; Magri M; Selvekerova S; Platin N; Kearney N; Patiraki E
    Complement Ther Clin Pract; 2005 May; 11(2):105-10. PubMed ID: 15955292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of complementary and alternative (non-conventional) medicine in cancer patients in Turkey.
    Algier LA; Hanoglu Z; Ozden G; Kara F
    Eur J Oncol Nurs; 2005 Jun; 9(2):138-46. PubMed ID: 15899593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of complementary and alternative medicine in patients with cancer: a UK survey.
    Scott JA; Kearney N; Hummerston S; Molassiotis A
    Eur J Oncol Nurs; 2005 Jun; 9(2):131-7. PubMed ID: 15944106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complementary and alternative medicine use in patients with head and neck cancers in Europe.
    Molassiotis A; Ozden G; Platin N; Scott JA; Pud D; Fernandez-Ortega P; Milovics L; Panteli V; Gudmundsdottir G; Browall M; Madsen E; Patiraki E; Kearney N
    Eur J Cancer Care (Engl); 2006 Mar; 15(1):19-24. PubMed ID: 16441673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of complementary and alternative therapies by cancer patients in northern Israel.
    Hana G; Bar-Sela G; Zhana D; Mashiach T; Robinson E
    Isr Med Assoc J; 2005 Apr; 7(4):243-7. PubMed ID: 15847205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequency of use of complementary and alternative medicine in women with breast cancer.
    Lengacher CA; Bennett MP; Kip KE; Keller R; LaVance MS; Smith LS; Cox CE
    Oncol Nurs Forum; 2002; 29(10):1445-52. PubMed ID: 12432415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of complementary medicine by adult patients participating in cancer clinical trials.
    Sparber A; Bauer L; Curt G; Eisenberg D; Levin T; Parks S; Steinberg SM; Wootton J
    Oncol Nurs Forum; 2000 May; 27(4):623-30. PubMed ID: 10833691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complementary and alternative medicine use by women after completion of allopathic treatment for breast cancer.
    Henderson JW; Donatelle RJ
    Altern Ther Health Med; 2004; 10(1):52-7. PubMed ID: 14727500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Why some cancer patients choose complementary and alternative medicine instead of conventional treatment.
    Shumay DM; Maskarinec G; Kakai H; Gotay CC;
    J Fam Pract; 2001 Dec; 50(12):1067. PubMed ID: 11742609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors predicting the use of complementary and alternative therapies among cancer patients in Iran.
    Montazeri A; Sajadian A; Ebrahimi M; Haghighat S; Harirchi I
    Eur J Cancer Care (Engl); 2007 Mar; 16(2):144-9. PubMed ID: 17371423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design and testing of the use of a complementary and alternative therapies survey in women with breast cancer.
    Lengacher CA; Bennett MP; Kipp KE; Berarducci A; Cox CE
    Oncol Nurs Forum; 2003; 30(5):811-21. PubMed ID: 12949594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of complementary and alternative medicine among patients with chronic diseases at outpatient clinics.
    Hasan SS; Ahmed SI; Bukhari NI; Loon WC
    Complement Ther Clin Pract; 2009 Aug; 15(3):152-7. PubMed ID: 19595416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patterns of the use of complementary and alternative medicine in women with metastatic cancer.
    Yildirim Y
    Cancer Nurs; 2010; 33(3):194-200. PubMed ID: 20357652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of complementary and alternative medicine by cancer patients at the University of Nigeria Teaching Hospital, Enugu, Nigeria.
    Ezeome ER; Anarado AN
    BMC Complement Altern Med; 2007 Sep; 7():28. PubMed ID: 17850665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of complementary/alternative medicine by cancer patients in a New Zealand regional cancer treatment centre.
    Chrystal K; Allan S; Forgeson G; Isaacs R
    N Z Med J; 2003 Jan; 116(1168):U296. PubMed ID: 12601420
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sex differences in motives for use of complementary and alternative medicine among cancer patients.
    Hedderson MM; Patterson RE; Neuhouser ML; Schwartz SM; Bowen DJ; Standish LJ; Marshall LM
    Altern Ther Health Med; 2004; 10(5):58-64. PubMed ID: 15478787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessing the role of evidence in patients' evaluation of complementary therapies: a quality study.
    Verhoef MJ; Mulkins A; Carlson LE; Hilsden RJ; Kania A
    Integr Cancer Ther; 2007 Dec; 6(4):345-53. PubMed ID: 18048882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.